Fox Rothschild's Marc Wagner on why scaling drug production is so slow — overseas API sourcing, supplier qualification, and FDA site approvals that take years.
|Videos|November 22, 2022
PharmExec Interviews at Pharma Lalarukh Haris Shaikh 2022
Advertisement
In this video, “Lala” Haris Shaikh, PhD, Executive Vice President, Life Sciences & Biotech, Palantir Technologies discusses the digital transformation with pharma data, how that can be done, data insights for pharma leaders as well as data interoperability and integration issues.
Advertisement
Related to this article
Waiting for perfect data before deploying AI is a trap — and why 60-70% accuracy is often good enough to start.
Fox Rothschild's Marc Wagner on why the FDA counts 70 drugs in shortage while ASHP counts 188 — and what's driving the gap.
Pharma's chain of custody model is migrating into food and consumer goods — and becoming a cross-industry differentiator.
Pharma logistics are overqualified by design — and how agentic AI can now optimize across thousands of lanes in days, not months.
Pharma AI adoption fails not because of the technology — but because organizations deploy tools before they're ready to use them.
Advertisement
Advertisement
Trending on PharmExec
1
Prediction Markets Expose a Gap in Pharmaceutical Vendor Contracts
2
The Bottlenecks That Slow Manufacturer Response to Increased Demand for Production
3
The Manufacturing Issues That Continue to Contribute to Drug Shortages
4
Bausch + Lomb Appoints Thomas Appio as Interim CEO
5